- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/17 - LymphocytesLymphocytes BLymphocytes TCellules tueuses naturellesLymphocytes activés par un interféron ou une cytokine
Détention brevets de la classe A61K 35/17
Brevets de cette classe: 12072
Historique des publications depuis 10 ans
|
484
|
694
|
1051
|
1266
|
1423
|
1560
|
1357
|
1435
|
966
|
396
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1127 |
503 |
| The Regents of the University of California | 20720 |
292 |
| The Trustees of the University of Pennsylvania | 4414 |
243 |
| Iovance Biotherapeutics, Inc. | 371 |
205 |
| Board of Regents, The University of Texas System | 6102 |
200 |
| Memorial Sloan-Kettering Cancer Center | 2038 |
185 |
| The Board of Trustees of the Leland Stanford Junior University | 6644 |
133 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
116 |
| Juno Therapeutics, Inc. | 519 |
112 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1018 |
110 |
| The General Hospital Corporation | 4858 |
104 |
| Baylor College of Medicine | 1001 |
90 |
| City of Hope | 1027 |
87 |
| Dana-Farber Cancer Institute, Inc. | 2662 |
87 |
| Autolus Limited | 266 |
84 |
| Cellectis | 415 |
83 |
| Regents of the University of Minnesota | 2785 |
78 |
| Immunitybio, Inc. | 507 |
76 |
| Novartis AG | 10263 |
68 |
| Fred Hutchinson Cancer Center | 474 |
68 |
| Autres propriétaires | 9148 |